Immune Pharmaceuticals Announces Publication of New Data on...

2016-02-27T12:59:23-08:00

NEW YORK, Feb. 24, 2016 /PRNewswire/ — Immune Pharmaceuticals Inc. (NASDAQ: IMNP), “Immune”, a clinical-stage biopharmaceutical company, announces publication of new data on the role of eotaxin-1 in Ulcerative Colitis ...